Literature DB >> 24754626

Oxidative stress and autonomic dysregulation contribute to the acute time-dependent myocardial depressant effect of ethanol in conscious female rats.

Badr M Ibrahim1, Ming Fan, Abdel A Abdel-Rahman.   

Abstract

BACKGROUND: The molecular mechanisms of the acute hypotensive and indirectly assessed cardiac depressant effect of ethanol (EtOH)-evoked myocardial depression and hypotension in female rats are not known. We tested the hypothesis that a time-dependent myocardial depression caused by EtOH is initiated by its direct and indirect (cardiac vagal dominance) effects and is exacerbated by gradual development of oxidative stress.
METHODS: In conscious female rats, we directly measured left ventricular developed pressure (LVDP), the maximal rise of ventricular pressure over time (dP/dtmax ), blood pressure (BP), heart rate (HR), and sympathovagal activity following intragastric EtOH (1 g/kg) or water over 90 minutes. Catalytic activity of acetaldehyde (ACA)-generating (alcohol dehydrogenase [ADH] and catalase) and eliminating aldehyde dehydrogenase [ALDH2] enzymes along with mediators of oxidative stress were measured in myocardial tissues collected at 30, 60, or 90 minutes after EtOH or water.
RESULTS: EtOH reduced myocardial function (LVDP and dP/dtmax ) within 5 to 10 minutes before the steady fall in BP in conscious proestrus rats. Further, EtOH shifted the sympathovagal balance, analyzed by spectral analysis of high frequency and low frequency of interbeat intervals, toward vagal dominance. Prior vagal blockade (atropine) or antioxidant (tempol) treatment attenuated EtOH-evoked myocardial depression and hypotension. Ex vivo studies revealed time-dependent: (i) enhancement of ADH, but not ALDH2 activity (indicative of elevated ACA levels), (ii) increases in phosphorylated Akt and ERK1/2, NADPH-oxidase activity, reactive oxygen species, malondialdehyde, and 4-hydroxy-2-nonenal-modified proteins. These molecular responses along with reduced myocardial catalase activity were most evident at 90 minutes post-EtOH when the reductions in cardiac function and BP reached their nadir.
CONCLUSIONS: Vagal dominance and time-dependent myocardial oxidative stress along with the accumulation of cardiotoxic aldehydes mediate EtOH-evoked myocardial dysfunction and hypotension in conscious proestrus female rats.
Copyright © 2014 by the Research Society on Alcoholism.

Entities:  

Keywords:  Ethanol; Female Rats; Hypotension; Myocardial Dysfunction; Reactive Oxygen Species

Mesh:

Substances:

Year:  2014        PMID: 24754626      PMCID: PMC3999510          DOI: 10.1111/acer.12363

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  52 in total

1.  Hemodynamic determinants of the time-course of fall in canine left ventricular pressure.

Authors:  J L Weiss; J W Frederiksen; M L Weisfeldt
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

2.  Acute adenosine increases cardiac vagal and reduces sympathetic efferent nerve activities in rats.

Authors:  Valdo Jose Dias da Silva; Tomaso Gnecchi-Ruscone; Valentina Bellina; Mauro Oliveira; Leonardo Maciel; Antonio Carlos Campos de Carvalho; Helio Cesar Salgado; Cassia M Bergamaschi; Eleonora Tobaldini; Alberto Porta; Nicola Montano
Journal:  Exp Physiol       Date:  2012-02-24       Impact factor: 2.969

3.  Sexually dimorphic hemodynamic effects of intragastric ethanol in conscious rats.

Authors:  M M El-Mas; A A Abdel-Rahman
Journal:  Clin Exp Hypertens       Date:  1999-11       Impact factor: 1.749

4.  Time constant of isovolumic pressure fall: determinants in the working left ventricle.

Authors:  J W Frederiksen; J L Weiss; M L Weisfeldt
Journal:  Am J Physiol       Date:  1978-12

5.  Overexpression of alcohol dehydrogenase exacerbates ethanol-induced contractile defect in cardiac myocytes.

Authors:  Jinhong Duan; Grant E McFadden; Anthony J Borgerding; Faye L Norby; Bonnie H Ren; Gang Ye; Paul N Epstein; Jun Ren
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-04       Impact factor: 4.733

6.  Influence of gender on ethanol-induced ventricular myocyte contractile depression in transgenic mice with cardiac overexpression of alcohol dehydrogenase.

Authors:  Jinhong Duan; Lucy B Esberg; Gang Ye; Anthony J Borgerding; Bonnie H Ren; Nicholas S Aberle; Paul N Epstein; Jun Ren
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2003-03       Impact factor: 2.320

7.  Determination of cardiac contractility in awake unsedated mice with a fluid-filled catheter.

Authors:  Qing Wang; Hans R Brunner; Michel Burnier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-09-25       Impact factor: 4.733

8.  Effects of elevated female sex steroids on ethanol and acetaldehyde metabolism in humans.

Authors:  C M Jeavons; A R Zeiner
Journal:  Alcohol Clin Exp Res       Date:  1984 Jul-Aug       Impact factor: 3.455

9.  Activation of phosphoinositide 3-kinase in response to high glucose leads to regulation of reactive oxygen species-related nuclear factor-kappaB activation and cyclooxygenase-2 expression in mesangial cells.

Authors:  Meei Ling Sheu; Feng Ming Ho; Kuo Fang Chao; Ming Liang Kuo; Shing Hwa Liu
Journal:  Mol Pharmacol       Date:  2004-07       Impact factor: 4.436

10.  Enhanced vascular neuronal nitric-oxide synthase-derived nitric-oxide production underlies the pressor response caused by peripheral N-methyl-D-aspartate receptor activation in conscious rats.

Authors:  Marie A McGee; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2012-05-11       Impact factor: 4.030

View more
  16 in total

Review 1.  Role of Alcohol Oxidative Metabolism in Its Cardiovascular and Autonomic Effects.

Authors:  Mahmoud M El-Mas; Abdel A Abdel-Rahman
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 2.  Alcoholic Cardiomyopathy: Disrupted Protein Balance and Impaired Cardiomyocyte Contractility.

Authors:  Jennifer L Steiner; Charles H Lang
Journal:  Alcohol Clin Exp Res       Date:  2017-05-29       Impact factor: 3.455

3.  Combined Catalase and ADH Inhibition Ameliorates Ethanol-Induced Myocardial Dysfunction Despite Causing Oxidative Stress in Conscious Female Rats.

Authors:  Fanrong Yao; Abdel A Abdel-Rahman
Journal:  Alcohol Clin Exp Res       Date:  2017-07-25       Impact factor: 3.455

Review 4.  Influence of sex on cardiovascular drug responses: role of estrogen.

Authors:  Abdel A Abdel-Rahman
Journal:  Curr Opin Pharmacol       Date:  2017-03-21       Impact factor: 5.547

5.  Abnormal cannabidiol confers cardioprotection in diabetic rats independent of glycemic control.

Authors:  Asmaa I Matouk; Ashraf Taye; Mohamed A El-Moselhy; Gehan H Heeba; Abdel A Abdel-Rahman
Journal:  Eur J Pharmacol       Date:  2017-12-20       Impact factor: 4.432

6.  Aldehyde Dehydrogenase Inhibition Ameliorates Cardiac Dysfunction and Exacerbates Hypotension Caused by Alcohol in Female Rats.

Authors:  Fanrong Yao; Abdel A Abdel-Rahman
Journal:  Alcohol Clin Exp Res       Date:  2019-11-24       Impact factor: 3.455

7.  Estrogen receptor ERα plays a major role in ethanol-evoked myocardial oxidative stress and dysfunction in conscious female rats.

Authors:  Fanrong Yao; Abdel A Abdel-Rahman
Journal:  Alcohol       Date:  2015-11-26       Impact factor: 2.405

8.  Estrogen Receptors α and β Play Major Roles in Ethanol-Evoked Myocardial Oxidative Stress and Dysfunction in Conscious Ovariectomized Rats.

Authors:  Fanrong Yao; Abdel A Abdel-Rahman
Journal:  Alcohol Clin Exp Res       Date:  2016-12-29       Impact factor: 3.455

Review 9.  Etiology of alcoholic cardiomyopathy: Mitochondria, oxidative stress and apoptosis.

Authors:  Jennifer L Steiner; Charles H Lang
Journal:  Int J Biochem Cell Biol       Date:  2017-06-09       Impact factor: 5.085

10.  The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats.

Authors:  Asmaa I Matouk; Ashraf Taye; Mohamed A El-Moselhy; Gehan H Heeba; Abdel A Abdel-Rahman
Journal:  J Cardiovasc Pharmacol       Date:  2017-01       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.